reICB regimen (melanoma): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving reICB regimen (melanoma)

• Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade
  NCT07130032 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve reICB regimen (melanoma)?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.